Best Laser surgery doctors in Israel: TOP 4 doctors

Prof. Merimsky leads the Unit for Soft Tissue and Bone Oncology at Sourasky Medical Center, specializing in advanced laser surgery techniques.

• Over 41 years of experience of experience in orthopedic oncology
• Fellowship-trained in sarcoma treatment at Institut Gustave Roussy, Paris
• Member of European Society of Medical Oncology (ESMO) Sarcoma Faculty
• Published extensive research on cancer treatment outcomes

Professor Dan Grisaro leads gynecological oncology at Sourasky Medical Center, specializing in laser surgery for cancers.

• Head of obstetrics and gynecology at Ichilov Sourasky
• Specialized in gynecology oncology at University of Toronto
• Author of 83 scientific articles on gynecologic cancers
• Member of American Society of Gynecologic Oncology

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.